Neurocrine Biosciences Inc (NBIX) — Capital Reinvestment Ratio
Neurocrine Biosciences Inc (NBIX) has a Capital Reinvestment Ratio of 0.01x as of December 2025, meaning it reinvests 0% of its operating cash flow ($388.40 Million) in capital expenditures ($2.40 Million). Check NBIX tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Neurocrine Biosciences Inc Capital Reinvestment Ratio (1996–2025)
This chart tracks Neurocrine Biosciences Inc's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see Neurocrine Biosciences Inc (NBIX) cash conversion ratio.
Annual Capital Reinvestment Ratio for Neurocrine Biosciences Inc (1996–2025)
Year-by-year Capital Reinvestment Ratio for Neurocrine Biosciences Inc from 1996 to 2025. See NBIX free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | $782.70 Million | $34.00 Million | ▼ -32.3% |
| 2024 | 0.06x | $595.40 Million | $38.20 Million | ▼ -11.6% |
| 2023 | 0.07x | $389.90 Million | $28.30 Million | ▲ +49.3% |
| 2022 | 0.05x | $339.40 Million | $16.50 Million | ▼ -46.7% |
| 2021 | 0.09x | $256.50 Million | $23.40 Million | ▲ +91.2% |
| 2020 | 0.05x | $228.50 Million | $10.90 Million | ▼ -52.3% |
| 2019 | 0.10x | $147.00 Million | $14.70 Million | ▼ -59.1% |
| 2018 | 0.24x | $101.40 Million | $24.80 Million | ▲ +3777.7% |
| 2010 | 0.01x | $49.94 Million | $315.00K | ▼ -99.5% |
| 2003 | 1.36x | $37.13 Million | $50.44 Million | ▲ +133.5% |
| 1997 | 0.58x | $11.00 Million | $6.40 Million | ▲ +143.6% |
| 1996 | 0.24x | $6.70 Million | $1.60 Million | — |